Antipsychotics and obsessive-compulsive disorder/obsessive-compulsive symptoms: A pharmacovigilance study of the FDA adverse event reporting system. - Burk BG; DiGiacomo T; Polancich S; Pruett BS; Sivaraman S; Birur B (Acta psychiatrica Scandinavica, 2023)